Barkinge J - Search Results

1

Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB.

Gudi R, Barkinge J, Hawkins S, Prabhakar B, Kanteti P. Gudi R, et al. Among authors: barkinge j. J Environ Pathol Toxicol Oncol. 2009;28(1):25-38. doi: 10.1615/jenvironpatholtoxicoloncol.v28.i1.30. J Environ Pathol Toxicol Oncol. 2009. PMID: 19392652 Free PMC article.

2

Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.

Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV. Chu F, et al. Among authors: barkinge j. Cancer Res. 2005 Jun 15;65(12):5301-9. doi: 10.1158/0008-5472.CAN-04-3270. Cancer Res. 2005. PMID: 15958577

3

Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD).

Gudi R, Barkinge J, Hawkins S, Chu F, Manicassamy S, Sun Z, Duke-Cohan JS, Prasad KV. Gudi R, et al. Among authors: barkinge j. Oncogene. 2006 Jun 8;25(24):3458-62. doi: 10.1038/sj.onc.1209381. Epub 2006 Feb 20. Oncogene. 2006. PMID: 16491128

4

The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.

Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV. Barkinge JL, et al. J Carcinog. 2009;8:2. doi: 10.4103/1477-3163.45389. J Carcinog. 2009. PMID: 19240372 Free PMC article.

5

The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.

Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S, Prasad KV. Chu F, et al. Among authors: barkinge j. Apoptosis. 2004 Jan;9(1):83-95. doi: 10.1023/B:APPT.0000012125.01799.4c. Apoptosis. 2004. PMID: 14739602

6

Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.

Hause RJ Jr, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Hause RJ Jr, et al. Among authors: barkinge jl. PLoS One. 2012;7(9):e44471. doi: 10.1371/journal.pone.0044471. Epub 2012 Sep 4. PLoS One. 2012. PMID: 22973453 Free PMC article.

7

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. Wojcik J, et al. Among authors: barkinge j. Nat Struct Mol Biol. 2010 Apr;17(4):519-27. doi: 10.1038/nsmb.1793. Epub 2010 Mar 28. Nat Struct Mol Biol. 2010. PMID: 20357770 Free PMC article.

8

Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective.

Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Chuu CP, et al. Among authors: barkinge jl. Mol Cancer Res. 2008 Jun;6(6):885-91. doi: 10.1158/1541-7786.MCR-07-0369. Mol Cancer Res. 2008. PMID: 18567793 Review.

9

Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.

Leung KK, Hause RJ Jr, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Leung KK, et al. Among authors: barkinge jl. Mol Cell Proteomics. 2014 Jul;13(7):1705-23. doi: 10.1074/mcp.M113.034876. Epub 2014 Apr 12. Mol Cell Proteomics. 2014. PMID: 24728074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters